Suppression effect on IFN-γ of adipose tissue-derived mesenchymal stem cells isolated from β2-microglobulin-deficient mice

Junko Masuda, Eiji Takayama, Tatsuo Ichinohe, Warren Strober, Masako Mizuno-Kamiya, Tomokatsu Ikawa, Atsushi Kitani, Harumi Kawaki, Ivan Fuss, Hiroshi Kawamoto, Akimasa Seno, Arun Vaidyanath, Naoki Umemura, Akifumi Mizutani, Tomonari Kasai, Yasuko Honjo, Ayano Satoh, Hiroshi Murakami, Yoshimoto Katsura, Nobuo KondohMasaharu Seno

Research output: Contribution to journalArticle

Abstract

Administration of bone marrow-derived mesenchymal stem cells (MSCs) is a possible treatment for graft-versus-host disease (GVHD) following allogeneic hematopoietic stem cell transplantation and other inflammatory conditions. To address the mechanism of immunosuppression by MSCs, in particular those derived from adipose tissue (AMSCs), AMSCs were isolated from three different mouse strains, and the suppressive capacity of the AMSCs thus obtained to suppress interferon (IFN)-γ generation in mixed lymphocyte reaction cultures serving as an in vitro model of GVHD were assessed. It was revealed that the AMSCs had a potent capacity to suppress IFN-γ production regardless of their strain of origin and that such suppression was not associated with production of interleukin-10. In addition, the results demonstrated that β2-microglobulin (β2m)-deficient AMSCs from β2m-/- mice were also potent suppressor cells, verifying the fact that the mechanism underlying the suppression by AMSCs is independent of major histocompatibility complex (MHC) class I expression or MHC compatibility. As AMSCs appear to have immunosuppressive properties, AMSCs may be a useful source of biological suppressor cells for the control of GVHD in humans.

Original languageEnglish
Pages (from-to)4277-4282
Number of pages6
JournalExperimental and Therapeutic Medicine
Volume16
Issue number5
DOIs
Publication statusPublished - Nov 1 2018

Fingerprint

Graft vs Host Disease
Mesenchymal Stromal Cells
Interferons
Adipose Tissue
Major Histocompatibility Complex
Mixed Lymphocyte Culture Test
Hematopoietic Stem Cell Transplantation
Immunosuppressive Agents
Interleukin-10
Immunosuppression
Bone Marrow
Therapeutics

Keywords

  • Adipose tissue-derived mesenchymal stem cells
  • Graft vs. host disease
  • Major histocompatibility complex class I
  • β2-microglobulin

ASJC Scopus subject areas

  • Immunology and Microbiology (miscellaneous)
  • Cancer Research

Cite this

Suppression effect on IFN-γ of adipose tissue-derived mesenchymal stem cells isolated from β2-microglobulin-deficient mice. / Masuda, Junko; Takayama, Eiji; Ichinohe, Tatsuo; Strober, Warren; Mizuno-Kamiya, Masako; Ikawa, Tomokatsu; Kitani, Atsushi; Kawaki, Harumi; Fuss, Ivan; Kawamoto, Hiroshi; Seno, Akimasa; Vaidyanath, Arun; Umemura, Naoki; Mizutani, Akifumi; Kasai, Tomonari; Honjo, Yasuko; Satoh, Ayano; Murakami, Hiroshi; Katsura, Yoshimoto; Kondoh, Nobuo; Seno, Masaharu.

In: Experimental and Therapeutic Medicine, Vol. 16, No. 5, 01.11.2018, p. 4277-4282.

Research output: Contribution to journalArticle

Masuda, J, Takayama, E, Ichinohe, T, Strober, W, Mizuno-Kamiya, M, Ikawa, T, Kitani, A, Kawaki, H, Fuss, I, Kawamoto, H, Seno, A, Vaidyanath, A, Umemura, N, Mizutani, A, Kasai, T, Honjo, Y, Satoh, A, Murakami, H, Katsura, Y, Kondoh, N & Seno, M 2018, 'Suppression effect on IFN-γ of adipose tissue-derived mesenchymal stem cells isolated from β2-microglobulin-deficient mice', Experimental and Therapeutic Medicine, vol. 16, no. 5, pp. 4277-4282. https://doi.org/10.3892/etm.2018.6689
Masuda, Junko ; Takayama, Eiji ; Ichinohe, Tatsuo ; Strober, Warren ; Mizuno-Kamiya, Masako ; Ikawa, Tomokatsu ; Kitani, Atsushi ; Kawaki, Harumi ; Fuss, Ivan ; Kawamoto, Hiroshi ; Seno, Akimasa ; Vaidyanath, Arun ; Umemura, Naoki ; Mizutani, Akifumi ; Kasai, Tomonari ; Honjo, Yasuko ; Satoh, Ayano ; Murakami, Hiroshi ; Katsura, Yoshimoto ; Kondoh, Nobuo ; Seno, Masaharu. / Suppression effect on IFN-γ of adipose tissue-derived mesenchymal stem cells isolated from β2-microglobulin-deficient mice. In: Experimental and Therapeutic Medicine. 2018 ; Vol. 16, No. 5. pp. 4277-4282.
@article{a3f89e175b954e1d99d8d44e02ce0a98,
title = "Suppression effect on IFN-γ of adipose tissue-derived mesenchymal stem cells isolated from β2-microglobulin-deficient mice",
abstract = "Administration of bone marrow-derived mesenchymal stem cells (MSCs) is a possible treatment for graft-versus-host disease (GVHD) following allogeneic hematopoietic stem cell transplantation and other inflammatory conditions. To address the mechanism of immunosuppression by MSCs, in particular those derived from adipose tissue (AMSCs), AMSCs were isolated from three different mouse strains, and the suppressive capacity of the AMSCs thus obtained to suppress interferon (IFN)-γ generation in mixed lymphocyte reaction cultures serving as an in vitro model of GVHD were assessed. It was revealed that the AMSCs had a potent capacity to suppress IFN-γ production regardless of their strain of origin and that such suppression was not associated with production of interleukin-10. In addition, the results demonstrated that β2-microglobulin (β2m)-deficient AMSCs from β2m-/- mice were also potent suppressor cells, verifying the fact that the mechanism underlying the suppression by AMSCs is independent of major histocompatibility complex (MHC) class I expression or MHC compatibility. As AMSCs appear to have immunosuppressive properties, AMSCs may be a useful source of biological suppressor cells for the control of GVHD in humans.",
keywords = "Adipose tissue-derived mesenchymal stem cells, Graft vs. host disease, Major histocompatibility complex class I, β2-microglobulin",
author = "Junko Masuda and Eiji Takayama and Tatsuo Ichinohe and Warren Strober and Masako Mizuno-Kamiya and Tomokatsu Ikawa and Atsushi Kitani and Harumi Kawaki and Ivan Fuss and Hiroshi Kawamoto and Akimasa Seno and Arun Vaidyanath and Naoki Umemura and Akifumi Mizutani and Tomonari Kasai and Yasuko Honjo and Ayano Satoh and Hiroshi Murakami and Yoshimoto Katsura and Nobuo Kondoh and Masaharu Seno",
year = "2018",
month = "11",
day = "1",
doi = "10.3892/etm.2018.6689",
language = "English",
volume = "16",
pages = "4277--4282",
journal = "Experimental and Therapeutic Medicine",
issn = "1792-0981",
publisher = "Spandidos Publications",
number = "5",

}

TY - JOUR

T1 - Suppression effect on IFN-γ of adipose tissue-derived mesenchymal stem cells isolated from β2-microglobulin-deficient mice

AU - Masuda, Junko

AU - Takayama, Eiji

AU - Ichinohe, Tatsuo

AU - Strober, Warren

AU - Mizuno-Kamiya, Masako

AU - Ikawa, Tomokatsu

AU - Kitani, Atsushi

AU - Kawaki, Harumi

AU - Fuss, Ivan

AU - Kawamoto, Hiroshi

AU - Seno, Akimasa

AU - Vaidyanath, Arun

AU - Umemura, Naoki

AU - Mizutani, Akifumi

AU - Kasai, Tomonari

AU - Honjo, Yasuko

AU - Satoh, Ayano

AU - Murakami, Hiroshi

AU - Katsura, Yoshimoto

AU - Kondoh, Nobuo

AU - Seno, Masaharu

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Administration of bone marrow-derived mesenchymal stem cells (MSCs) is a possible treatment for graft-versus-host disease (GVHD) following allogeneic hematopoietic stem cell transplantation and other inflammatory conditions. To address the mechanism of immunosuppression by MSCs, in particular those derived from adipose tissue (AMSCs), AMSCs were isolated from three different mouse strains, and the suppressive capacity of the AMSCs thus obtained to suppress interferon (IFN)-γ generation in mixed lymphocyte reaction cultures serving as an in vitro model of GVHD were assessed. It was revealed that the AMSCs had a potent capacity to suppress IFN-γ production regardless of their strain of origin and that such suppression was not associated with production of interleukin-10. In addition, the results demonstrated that β2-microglobulin (β2m)-deficient AMSCs from β2m-/- mice were also potent suppressor cells, verifying the fact that the mechanism underlying the suppression by AMSCs is independent of major histocompatibility complex (MHC) class I expression or MHC compatibility. As AMSCs appear to have immunosuppressive properties, AMSCs may be a useful source of biological suppressor cells for the control of GVHD in humans.

AB - Administration of bone marrow-derived mesenchymal stem cells (MSCs) is a possible treatment for graft-versus-host disease (GVHD) following allogeneic hematopoietic stem cell transplantation and other inflammatory conditions. To address the mechanism of immunosuppression by MSCs, in particular those derived from adipose tissue (AMSCs), AMSCs were isolated from three different mouse strains, and the suppressive capacity of the AMSCs thus obtained to suppress interferon (IFN)-γ generation in mixed lymphocyte reaction cultures serving as an in vitro model of GVHD were assessed. It was revealed that the AMSCs had a potent capacity to suppress IFN-γ production regardless of their strain of origin and that such suppression was not associated with production of interleukin-10. In addition, the results demonstrated that β2-microglobulin (β2m)-deficient AMSCs from β2m-/- mice were also potent suppressor cells, verifying the fact that the mechanism underlying the suppression by AMSCs is independent of major histocompatibility complex (MHC) class I expression or MHC compatibility. As AMSCs appear to have immunosuppressive properties, AMSCs may be a useful source of biological suppressor cells for the control of GVHD in humans.

KW - Adipose tissue-derived mesenchymal stem cells

KW - Graft vs. host disease

KW - Major histocompatibility complex class I

KW - β2-microglobulin

UR - http://www.scopus.com/inward/record.url?scp=85053854159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053854159&partnerID=8YFLogxK

U2 - 10.3892/etm.2018.6689

DO - 10.3892/etm.2018.6689

M3 - Article

AN - SCOPUS:85053854159

VL - 16

SP - 4277

EP - 4282

JO - Experimental and Therapeutic Medicine

JF - Experimental and Therapeutic Medicine

SN - 1792-0981

IS - 5

ER -